Ex-Dividend Reminder: CNO Financial Group, Cohen & Steers Tax-advantaged Preferred Securities and Elevance Health

CNO Financial Group (CNO), Cohen & Steers Tax-advantaged Preferred Securities (PTA), and Elevance Health (ELV) will trade ex-dividend on June 10, 2025, with respective dividend payments of $0.17, $0.134, and $1.71. This equates to an approximate opening price decrease of 0.45% for CNO, 0.68% for PTA, and 0.44% for ELV, all else being equal; ELV, with 14+ years of dividend increases, is noted as a future dividend aristocrat contender.

Analysis

CNO Financial Group Inc (CNO), Cohen & Steers Tax-advantaged Preferred Securities (PTA), and Elevance Health Inc (ELV) are scheduled to trade ex-dividend on June 10, 2025. CNO will pay a quarterly dividend of $0.17 on June 24, 2025, representing approximately 0.45% of its recent stock price of $37.86, leading to an expected equivalent price decrease at market open on the ex-dividend date. PTA will distribute a monthly dividend of $0.134 on June 30, 2025, with an anticipated 0.68% opening price reduction. ELV is set to pay a quarterly dividend of $1.71 on June 25, 2025, implying an expected 0.44% price decline. Notably, Elevance Health is identified as a "future dividend aristocrats contender" due to its consistent record of over 14 years of dividend increases. The current estimated annualized yields are 1.80% for CNO, a substantial 8.17% for PTA, and 1.78% for ELV. In Friday's trading session preceding this announcement, CNO shares rose approximately 0.6%, PTA shares increased by about 0.7%, and ELV shares saw a more significant gain of around 1.2%. While these dividends are announced, their future predictability hinges on company profits, underscoring the need to assess historical payment stability.

Key Decisions for Investors

• Investors should anticipate a mechanical downward adjustment in the share prices of CNO, PTA, and ELV at the market open on June 10, 2025, reflecting the value of the distributed dividends.
• For those seeking high current income, PTA's estimated annualized yield of 8.17% is notable, however, thorough due diligence on its dividend sustainability and underlying asset quality is crucial.
• Elevance Health's status as a 'future dividend aristocrat contender' with over 14 years of dividend growth may appeal to investors prioritizing consistent and potentially increasing income streams alongside long-term capital growth.
• Before committing capital based on these payouts, investors should evaluate the historical dividend consistency and financial stability of CNO, PTA, and ELV, as dividend payments are not guaranteed and depend on ongoing profitability.